Pomerantz investigates NuScale after stock plunges 15.67% on UBS downgrade

Verifying
  • Pomerantz LLP is investigating NuScale and certain officers and directors for potential securities violations.
  • NuScale shares fell $1.60, or 15.67%, to close at $8.61 on September 11, 2026.
  • UBS downgraded NuScale from Neutral to Sell and cut its price target from $10 to $6.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.